GLP-1 Was Just the Beginning. The First Triple-Hormone Obesity Drug Now Has Phase 3 Data
For the last several years, one acronym has dominated the conversation around obesity treatment: GLP-1. First came drugs that targeted the…
Drug Development Takes More Than a Decade. A New Federal Program Wants to Cut Clinical Trials to Under Four Years.
Most pharmacists learn clinical development as a sequence of distinct steps. A drug enters Phase 1, moves into Phase 2 if the early evidence…
Insulin Just Went From 365 Injections a Year to 52. Now Two Once-Weekly Options Are Approved.
For more than a century, insulin has steadily evolved. We’ve developed faster insulins for meals, longer-acting insulins for basal…
CMS Is Asking Pharmacists to Help Write the Medicare Pharmacy Contract Rules PBMs Will Have to Follow
For years, pharmacists and pharmacy owners have raised concerns about Medicare Part D contracts that can be difficult to evaluate, difficult…
A New Study Put a Dollar Value on Pharmacist Led Medication Optimization: $246 Per Medicare Patient Per Month
Pharmacy has spent years making a familiar argument: pharmacists can improve medication use, prevent medication-related problems, and reduce…